Search
for
Sort by
Research 31–60 of 1000+
- Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia
- A randomized clinical trial on therapeutic effects of 0.25 mg oral minoxidil tablets on treatment of female pattern hair loss
- การศึกษาแบบสุ่มและทดสอบความไม่ด้อยกว่า ของ ยาไมนอกซิดิลชนิดรับประทานขนาด 1.25 มิลลิกรัมต่อวัน เปรียบเทียบกับ ยาทา5%ไมนอกซิดิลในการรักษาโรคผมบางจากพันธุกรรมในเพศหญิง
- Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair loss: 0.25 mg versus 1 mg
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Immunolocalization of 5α-Reductase Isozymes in Acne Lesions and Normal Skin
- Investigation of Antioxidant Activity of Cynanchi Wilfordii Radix and Inhibitory Effect of 5α-reductase mRNA in Human Dermal Papilla Cells
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- Management of Hair Loss
- Pharmacological therapeutics in androgenetic alopecia
- Herbal Extracts Induce Dermal Papilla Cell Proliferation of Human Hair Follicles
- Finasteride와 저용량 Dutasteride 병용요법으로 호전된 안드로겐성 탈모증 1예
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Clinical biochemistry of dihydrotestosterone
- Can plant‐derived phytochemicals provide symptom relief for hair loss? A critical review
- Effect of the multifunctional cosmetic ingredient sphinganine on hair loss in men and women with diffuse hair reduction
- 5α-Reductase underscores the development of pectoral fin breeding tubercles in zebrafish
- The Biomolecular Effects of Finasteride on Male Rat Brain during Administration and after Discontinuation
- IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
- The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases